Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Dianthus Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- +7 vs. Q1 2021
- Shares held
- 37.5M
- +2.12M (+6.0%) vs. Q1 2021
- Total value
- $366.3M
- −$52.0M (−12.4%) vs. Q1 2021
- New holders
- 16
- 39 more added
- Sold out
- 9
- 22 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 269 | $6.40B |
| Q1 2026 | 241 | $5.18B |
| Q4 2025 | 166 | $2.02B |
| Q3 2025 | 140 | $1.84B |
| Q2 2025 | 103 | $728.6M |
| Q1 2025 | 99 | $685.5M |
| Q4 2024 | 96 | $765.7M |
| Q3 2024 | 91 | $858.7M |
| Q2 2024 | 74 | $768.8M |
| Q1 2024 | 76 | $782.3M |
| Q4 2023 | 39 | $106.5M |
| Q3 2023 | 30 | $136.3M |
| Q2 2023 | 46 | $22.0M |
| Q1 2023 | 52 | $23.6M |
| Q4 2022 | 54 | $11.1M |
| Q3 2022 | 72 | $65.8M |
| Q2 2022 | 75 | $54.6M |
| Q1 2022 | 93 | $138.9M |
| Q4 2021 | 94 | $211.4M |
| Q3 2021 | 93 | $276.0M |
| Q2 2021 | 97 | $366.3M |
| Q1 2021 | 90 | $418.4M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| California Public Employees Retirement System | 0 | $0 | 0.00% | −33,400−100.0% | Sold out |
| SeaCrest Wealth Management, LLC | 0 | $0 | 0.00% | −31,188−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −19,355−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −3,164−100.0% | Sold out |
| HM Payson & Co | 0 | $0 | 0.00% | −1,421−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −604−100.0% | Sold out |